Anticoagulant Treatment Requires Special Care in the Elderly.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 30, doi. 10.1177/155989771313016
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2013 AND VI 13 AND IP 13
Results: 16
1
2
Phenotyping and Genotyping of Platelet Disorders.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 29, doi. 10.1177/155989771313015
- By:
- Publication type:
- Article
3
TAFI(a) Assays Measure Extent of Activation in Patient Populations.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 28, doi. 10.1177/155989771313014
- By:
- Publication type:
- Article
4
Hemostatic Disorders in Women.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 26, doi. 10.1177/155989771313013
- By:
- Publication type:
- Article
5
Changing Paradigms regarding New Antiplatelet Therapy.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 24, doi. 10.1177/155989771313012
- By:
- Publication type:
- Article
6
Recurrent Venous Thrombosis.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 22, doi. 10.1177/155989771313011
- By:
- Publication type:
- Article
7
Advances in the Management of von Willebrand Disease and Hemophilia.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 18, doi. 10.1177/155989771313010
- By:
- Publication type:
- Article
8
Complement Inactive in E. coli Shiga Toxin-Producing Diseases.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 16, doi. 10.1177/155989771313009
- By:
- Publication type:
- Article
9
Protein Bioengineering Strategies Improve upon Hemophilia Treatments.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 15, doi. 10.1177/155989771313008
- By:
- Publication type:
- Article
10
Investigational Small Molecule Rapidly Reverses Effects of New Oral Anticoagulants, Heparins.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 14, doi. 10.1177/155989771313007
- By:
- Publication type:
- Article
11
Use of Dalteparin beyond 6 Months in Cancer Patients with VTE is Feasible.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 13, doi. 10.1177/155989771313006
- By:
- Publication type:
- Article
12
In Search of the Holy Grail of Anticoagulant Therapy.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
13
Apixaban is an Effective Replacement for Conventional Anticoagulation Therapy.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 11, doi. 10.1177/155989771313004
- By:
- Publication type:
- Article
14
Anticoagulation for Isolated Distal Deep Vein Thrombosis May Reduce Serious Complications.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 10, doi. 10.1177/155989771313003
- By:
- Publication type:
- Article
15
Mendelian Randomization as a Promising Approach to Define Which Biomarkers are Causal for Myocardial Infarction.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 6, doi. 10.1177/155989771313002
- By:
- Publication type:
- Article
16
Data from New Oral Anticoagulants Provide Clues for Future Drug Development.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 4, doi. 10.1177/155989771313001
- By:
- Publication type:
- Article